WITH THE SURGE IN IMMUNOTHERAPY RESEARCH, HEMACARE IS ‘UNIQUELY POSITIONED’ TO PROVIDE CRITICAL BLOOD AND TISSUE SAMPLES.
TOP GROWTH COMPANY
Monday, April 15, 2019
HemaCare Corp...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 26 biweekly issues
- Subscriber-only digital content for prime stories
- Book of Lists — the most comprehensive business resource in the Valley region